Advertisement
American Journal of Infection Control
Advanced searchSave search
Brief report| Volume 43, ISSUE 2, P185-187, February 01, 2015

Surveillance of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a comprehensive cancer center in Japan, 2009-2013

Published:December 17, 2014DOI:https://doi.org/10.1016/j.ajic.2014.11.005
Surveillance of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a comprehensive cancer center in Japan, 2009-2013
Previous ArticleA gap in patient tape storage and use practices puts patients at risk for cutaneous fungal infections
Next ArticleBurden of isolation for multidrug-resistant organisms in a tertiary public hospital in Southern Brazil

      Highlights

      • •
        Nosocomial epidemiology of extended-spectrum β-lactamase-producing organisms is not clarified in Japan.
      • •
        We focus on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing nosocomial outbreak.
      • •
        We retrospectively compare the occurrence of these 2 extended-spectrum β-lactamase-producing organisms.
      • •
        Our findings demonstrate an increase in the influx of Escherichia coli from the community.
      We examined the results of surveillance of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, which are pathogens known to cause nosocomial outbreaks, at a comprehensive cancer center in Japan over a 5-year period. We found that the admission prevalence and the incidence of ESBL-producing E coli increased during the study period, in contrast with ESBL-producing K pneumoniae, in which the parameters remained low throughout the study period.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Paterson D.L.
        • Bonomo R.A.
        Extended-spectrum beta-lactamases: a clinical update.
        Clin Microbiol Rev. 2005; 18: 657-686
        View in Article
        • Oteo J.
        • Perez-Vazquez M.
        • Campos J.
        Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact.
        Curr Opin Infect Dis. 2010; 23: 320-326
        View in Article
        • Matsumura Y.
        • Yamamoto M.
        • Nagao M.
        • Hotta G.
        • Matsushima A.
        • Ito Y.
        • et al.
        Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-beta-lactamase-producing Escherichia coli in Japan.
        J Antimicrob Chemother. 2012; 67: 2612-2620
        View in Article
        • Ohmagari N.
        • Kurai H.
        • Yamagishi Y.
        • Mikamo H.
        Are strict isolation policies based on susceptibility testing actually effective in the prevention of the nosocomial spread of multi-drug-resistant gram-negative rods?.
        Am J Infect Control. 2014; 42: 739-743
        View in Article
        • Clinical and Laboratory Standards Institute
        Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100–S19.
        Clinical and Laboratory Standards Institute, Wayne (PA)2009
        View in Article
        • Cohen A.L.
        • Calfee D.
        • Fridkin S.K.
        • Huang S.S.
        • Jernigan J.A.
        • Lautenbach E.
        • et al.
        Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper.
        Infect Control Hosp Epidemiol. 2008; 29: 901-913
        View in Article

      7. Japan Nosocomial Infections Surveillance. Available from: https://www.nih-janis.jp/english/index.asp. Accessed October 20, 2014.

        View in Article
        • Adler A.
        • Gniadkowski M.
        • Baraniak A.
        • Izdebski R.
        • Fiett J.
        • Hryniewicz W.
        • et al.
        Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre.
        Clin Microbiol Infect. 2012; 18: E497-E505
        View in Article
        • Tschudin-Sutter S.
        • Frei R.
        • Dangel M.
        • Stranden A.
        • Widmer A.F.
        Rate of transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae without contact isolation.
        Clin Infect Dis. 2012; 55: 1505-1511
        View in Article

      Article info

      Publication history

      Published online: December 17, 2014

      Footnotes

      Conflicts of interest: None to report.

      Identification

      DOI: https://doi.org/10.1016/j.ajic.2014.11.005

      Copyright

      © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX